Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2022-01-05 Director's Dealing
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2022-01-05 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The text includes details about a settlement framework related to litigation, specifically a settlement with Scott+Scott Attorneys at Law regarding opioid-related lawsuits. It is not a full financial report, earnings release, or management discussion. The document is a regulatory announcement of a material event, not a detailed financial or operational report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2021-12-28 English
PRIMARY DOCUMENT
Director's Dealing
2021-12-17 English
FORM 8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It announces a corporate restructuring involving headcount reduction and associated costs. The document does not contain financial statements or detailed financial analysis but rather reports a significant corporate event. Form 8-K filings are typically classified as Regulatory Filings (RNS) because they provide updates on material events but are not full financial reports or earnings releases. The document length is 5792 characters, which is sufficient for a detailed announcement but it is not an annual or quarterly report, nor an earnings release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-11-12 English
10-Q
Interim / Quarterly Report Q3 2021
2021-11-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 4, 2021, by Collegium Pharmaceutical, Inc. It announces the issuance of a press release with financial results for the quarterly period ended September 30, 2021. The document itself does not contain the financial results but rather furnishes the press release as an exhibit. The text explicitly states that the press release is attached as Exhibit 99.1 and is being furnished, not filed, under Item 2.02. The document length is 3440 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, such a document that announces or furnishes a report but does not contain substantive financial data itself should be classified as Regulatory Filings (RNS), the fallback category for miscellaneous filings that do not fit other categories. It is not an Earnings Release (ER) because it does not contain the financial highlights itself, only references the press release. It is not an Interim/Quarterly Report (IR) because it lacks actual financial statements or substantive financial data. Therefore, the correct classification is Regulatory Filings (RNS).
2021-11-04 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.